J Control Release. 2013 Dec 28;172(3):1002-10.
Commercial non-degradable glaucoma implants are often associated with undesired hypotony, fibrosis, long term failure, and damage of adjacent tissues, which may be overcome by a multifunctional polymeric microstent for suprachoroidal drainage. This study reports the design and fabrication of such devices with tailorable internal diameters (50-300 μm) by solvent-free, continuous hot melt extrusion from blends of poly[(ε-caprolactone)-co-glycolide] and poly(ε-caprolactone) [PCL]. A spatially directed release was supported by bilayered microstents with an internal drug-free PCL layer, and a quantitative description of release kinetics with diclofenac sodium as model drug was provided. Furthermore, the slow degradation pattern (> 1 year) was analyzed and potential effects of 1-5 wt.% drug loading on material properties were excluded. Translational aspects including sterilization by γ-irradiation on dry ice, in vitro biocompatibility, and in vivo implantation were addressed. The promising results support further functional analysis of long-term in vivo performance and suppression of disadvantageous capsule formation.
商用不可降解的青光眼植入物常伴有不期望的眼压降低、纤维化、长期失效和邻近组织损伤,而多功能聚合物微支架用于脉络膜下引流可克服这些问题。本研究报告了通过无溶剂、连续热熔挤出聚(ε-己内酯)-共-丙交酯和聚(ε-己内酯)[PCL]混合物来设计和制造这种具有可调节内径(50-300μm)的设备。双层微支架内部的无药物 PCL 层支持空间定向释放,并提供了以双氯芬酸钠为模型药物的释放动力学的定量描述。此外,还分析了缓慢的降解模式(>1 年),并排除了 1-5wt.%药物负载对材料性能的潜在影响。还涉及包括在干冰上进行γ辐照灭菌、体外生物相容性和体内植入的转化方面。有前景的结果支持进一步对长期体内性能和抑制不利囊形成的功能分析。